The global point-of-care molecular diagnostics market was estimated to be worth US$ 3 billion in 2021 and is expected to grow at a robust CAGR of 8% between 2022 and 2032, reaching around US$ 11 billion by 2032. The rising prevalence of infectious diseases and cancer worldwide, as well as growing end user preference for …